UNSPSC 85813702: Introduction of recombinant bone morphogenetic protein into joints, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of recombinant bone morphogenetic protein into joints, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0U0GB

UNSPSC 85813702 Introduction of recombinant bone morphogenetic protein into joints, open approach, Commodity, does not align with the recent state and local solicitation activity captured under this code. The fifteen most recent opportunities—ranging from emergency medical services administration to employee wellness platforms, occupational health screening, and behavioral health services—represent healthcare administration, occupational medicine, and clinical support functions with no connection to orthopedic surgical procedures or recombinant bone morphogenetic protein delivery. The code's nominal scope describes a specific surgical intervention, yet state and local procurement offices are issuing RFPs, RFQs, and ITBs for executive-level healthcare services such as medical director oversight, EMS billing, inmate healthcare management, cancer screening coordination, and administrative services delivery. This systematic mismatch suggests either a data classification error within the state and local procurement system or that the code has been misapplied to health services contracts that belong under clinical administration or healthcare staffing taxonomies.

The issuing bodies span diverse jurisdictions—Seminole County and Fulton County in Florida and Georgia respectively; Texas agencies including the Health and Human Services Commission and Department of Agriculture; Oregon Health Authority; Washington State Health Care Authority; Collier County and Harris Health in Florida; and independent school districts in multiple states—with no clear concentration by region or entity type. Opportunity types include RFPs predominating over RFQs and ITBs, with response deadlines clustered in June and July 2026. Without substantive alignment between the code's stated scope and actual procurement activity, this category presents no clear business development signal for firms positioned in orthopedic surgical product delivery or recombinant protein administration.